Physician profile
Krishna Murthy
NPI 1841293115
$5,870.07
in general payments reported to CMS, 2019-2025
40 companies · $740 in 2025
The $740 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,301 · 2020: $511 · 2021: $1,014 · 2022: $781 · 2023: $1,055 · 2024: $468 · 2025: $740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,263.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $679.06 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $621.04 | 2019-2023 | Farxiga |
| Amgen INC. | $558.68 | 2019-2025 | Repatha, Evenity, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $525.81 | 2022-2025 | |
| Lilly USA, LLC | $506.88 | 2019-2024 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $504.74 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $217.90 | 2021-2025 | Xience Skypoint, Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $210.34 | 2019-2025 | Glassia, Trintellix |
| Teva Pharmaceuticals USA, INC. | $175.34 | 2019-2021 | |
| Pfizer INC. | $153.65 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $143.12 | 2021-2023 | Camzyos |
| Travere Therapeutics, INC. | $124.99 | 2023 | |
| United Therapeutics Corporation | $122.79 | 2022 | |
| Novartis Pharmaceuticals Corporation | $121.53 | 2019-2024 | |
| Genentech USA, INC. | $112.77 | 2019 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishna Murthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.